期刊文献+

单基因遗传病检出策略 被引量:3

原文传递
导出
摘要 顾名思义.单基因遗传病是由单个基因异常引起的疾病。传统的单基因遗传病分为常染色体显性遗传、常染色体隐性遗传、X染色体显性遗传和X染色体隐性遗传,其均符合孟德尔遗传定律。现今的单基因疾病已扩展到印记基因疾病和线粒体疾病.而这两类单基因疾病是不遵循孟德尔遗传定律的。此外.以往对单基因疾病的认识主要局限在基因的编码区和序列变异.如今已扩展到基因的调控区和修饰异常。因此.对单基因疾病更为完整的定义应该是.单个基因编码区或调控区序列或修饰异常引起的疾病。
作者 马端
出处 《诊断学理论与实践》 2014年第1期12-15,共4页 Journal of Diagnostics Concepts & Practice
  • 相关文献

参考文献9

  • 1Genes and human disease[R/OL]. [2014-01-16].http://www. who.int/genomics/publie/geneticdiseases/en/index2,html.
  • 2马端,周文浩,黄国英.罕见病并不罕见[J].中国循证儿科杂志,2011,6(2):83-85. 被引量:15
  • 3Heim M, Meyer UA. Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification[J]. Lancet, 1990,336(8714):529-532.
  • 4Elaine KG. Allele-Specific Oligonucleotide PCR [J]. Me- thods in Molecular Biology,2002,187:47-50.
  • 5Batt SL, Charalambous BM, McHugh TD, et al. Novel PCR-restriction fragment length polymorphism method for determining serotypes or serogroups of Streptococcus pneumoniae isolates[J]. J Clin Microbiol,2005,43(6):2656- 2661.
  • 6Gravesen A, Warthoe P, Knochel S, et al. Restriction fragment differential display of pediocin-resistant Listeria monocytogenes 412 mutants shows consistent overexpres- sion of a putative beta-glucoside-specific PTS system[J]. Microbiology,2000,146(Pt 6):1381-1389.
  • 7Carmona M, Septlveda D, Ctrdenas C, et al Denaturing gradient gel electrophoresis (DGGE) as a powerful novel alternative for differentiation of epizootic ISA virus variants[J]. PLoS One,2012,7(5):e37353.
  • 8Dong Y, Zhu H. Single-strand conformational polymor- phism analysis: basic principles and routine practice [J]. Methods Mol Med,2005,108:149-157.
  • 9Crrpin M, Pigny P, Escande F, et al. Evaluation of dena- turing high performance liquid chromatography for the mutational analysis of the MEN1 gene[J]. J Mol Endocrinol, 2006,36(2):369-376.

二级参考文献6

  • 1Erik Tambuyzer. Rare diseases, orphan drugs and their regulation: questions and misconceptions. Nat Rev Drug Discov, 2010, 9(12) :921-929.
  • 2Heemstra H. H. From Research on rare diseases to new orphan drug development. Thesis, Utrecht Univ, Netherlands (2009).
  • 3http://www, accessdata, fda. gov/scripts/opdlisting/oopd/index. cfm.
  • 4http ://www. orpha, net/.
  • 5Liu BC, He L, He G, et al. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy. J Public Health Policy, 2010, 31 (4) :407-420.
  • 6Wang JB, Guo J J, Yang L, et al. Rare diseases and legislation in China. Lancet, 2010, 375(9716):708-709.

共引文献14

同被引文献32

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部